GLP-1 analogues: a new therapeutic approach to prevent ductopenia in cholangiopathies?
Beuers
Ulrich
U
Department of Gastroenterology & Hepatology, Academic Medical Center, University of Amsterdam, PO Box 22700, 1100 DE Amsterdam, The Netherlands. u.h.beuers@amc.uva.nl
Göke
Burkhard
B
D001649:Bile Duct Diseases / Q000188:drug therapy* / Q000473:pathology; D049109:Cell Proliferation / Q000187:drug effects; D000077270:Exenatide; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives* / Q000502:physiology; D006801:Humans; D054795:Incretins / Q000627:therapeutic use*; D010455:Peptides / Q000627:therapeutic use; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use; D014688:Venoms / Q000627:therapeutic use
D054795:Incretins; D010455:Peptides; D014688:Venoms; D014580:Ursodeoxycholic Acid; D052216:Glucagon-Like Peptide 1; D000077270:Exenatide